-
PRESERVING VISION AND PRODUCTIVITY: THE SOCIAL IMPACT OF INNOVATIVE DME THERAPY IN CHILE
Mar 18, 2026, 21:38 PM -
UPDATED COST-EFFECTIVENESS ANALYSIS OF POLATUZUMAB VEDOTIN COMBINED WITH CHEMOIMMUNOTHERAPY FOR UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN CHINA: EVIDENCE FROM LONG-TERM FOLLOW-UP OF THE POLARIX ASIAN SUBGROUP
Mar 18, 2026, 21:38 PM -
TEMPORAL TRENDS AND DETERMINANTS OF AORTIC VALVE REPLACEMENT IN PATIENTS WITH ASYMPTOMATIC SEVERE AORTIC STENOSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD MULTIPLE MYELOMA TREATMENT RESPONSES: EVALUATION OF FRONTLINE REGIMENS IN MELDTM LINKED MEDICARE, LABORATORY AND ELECTRONIC MEDICAL RECORDS...
Mar 18, 2026, 21:38 PM -
REAL-WORLD CHARACTERISTICS AND HEALTHCARE RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB IN SWEDEN: THE BIMENORDIX STUDY
Mar 18, 2026, 21:38 PM -
PRIORITIZING AND COSTING RMNCH INNOVATIONS FOR SCALABLE IMPACT: A COMBINED MCDA AND COSTING APPROACH FROM ETHIOPIA
Mar 18, 2026, 21:38 PM -
USE OF REAL-WORLD EVIDENCE ON US BRANDED HCP DRUG WEBSITES: AN AI-ENABLED CONTENT ANALYSIS
Mar 18, 2026, 21:38 PM -
HEALTHCARE UTILIZATION PATTERNS AMONG MEDICARE BENEFICIARIES WITH FINANCIAL CONSTRAINTS
Mar 18, 2026, 21:38 PM -
UTILIZATION, EXPENDITURE, AND PRICE TRENDS FOR EZETIMIBE AND NOVEL LIPID-LOWERING MEDICATIONS IN U.S. MEDICAID DRUG UTILIZATION DATA, 2002-2024
Mar 18, 2026, 21:38 PM -
DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS
Mar 18, 2026, 21:38 PM -
CAN A GENERATIVE PATIENT JOURNEY FOUNDATION MODEL ALLEVIATE THE BURDEN OF CANCER SCREENING?
Mar 18, 2026, 21:38 PM -
MEASURING PATIENT-REPORTED DERMATOLOGIC SIDE EFFECTS OF CANCER TREATMENT: PSYCHOMETRIC EVALUATION OF THE SKINDEX-16 IN NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN OF DIAGNOSED METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN US ADULTS WITH TYPE 2 DIABETES: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERNS AND HEALTHCARE COSTS IN PATIENTS WITH SMALL-CELL LUNG CANCER IN SOUTH KOREA: A NATIONWIDE REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
HOW THE EU JOINT CLINICAL ASSESSMENT UNCERTAINTIES IMPACT US PHARMACEUTICAL MARKET ACCESS
Mar 18, 2026, 21:38 PM -
THE ECONOMIC BURDEN OF HIV IN MEXICO: A LIFETIME COST-OF-ILLNESS ANALYSIS
Mar 18, 2026, 21:38 PM -
LEVERAGING GENERATIVE AI AND MACHINE LEARNING FOR ROBUST REAL-WORLD COHORT DEFINITION AND PATIENT JOURNEY INSIGHTS IN HIV RESEARCH
Mar 18, 2026, 21:38 PM -
EVIDENCE-BASED PICO MAPPING FOR EU JOINT CLINICAL ASSESSMENT (JCA) USING A REAL-TIME AI-ASSISTEDLIVINGSYSTEMATIC LITERATURE REVIEW (REAL-SLR): A METASTATIC BREAST CANCER CASE STUDY
Mar 18, 2026, 21:38 PM -
GENERAL-PURPOSE VS HEOR-SPECIFIC GENERATIVE AI IN RARE DISEASE MODELING: A DUCHENNE MUSCULAR DYSTROPHY CASE STUDY
Mar 18, 2026, 21:38 PM -
FAST TREATMENT EFFICACY TESTING VIA REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM
